Research Article

Liver disease in the Era of Coronavirus Disease 19 (COVID-19) pandemic

Siddesh Besur*, Rehana Begum, Vikraman Gunabushanam and Herbert L Bonkovsky

Published: 10/20/2020 | Volume 4 - Issue 1 | Pages: 052-057

Coronavirus infections have caused outbreaks in humans: SARS-COV ((Severe Acute Respiratory Syndrome) and MERS-CoV (Middle East Respiratory Syndrome) resulting in significant mortality and morbidity.

Read Full Article HTML DOI: 10.29328/journal.acgh.1001023 Cite this Article


  1. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020; 12: 9.
  2. Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565–574.
  3. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, et al. 2020. UK. COVID-19: consider cytokine storm syndromes and immunosuppression.
  4. Ruscitti P, Berardicurti O, Cipriani P, Iagnocco A, Shoenfeld Y. Severe hyper-inflammatory COVID-19, another piece in the puzzle of the “htperferritinemic syndrome”. Rheumatol Point View. 2020.
  5. Lan J, Ge J, Yu J, Shan S, Zhou H, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020; 581: 215-220. PubMed:
  6. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426: 450–454. PubMed:
  7. Chai X, Hu L, Zhang Y, Han W, Lu Z, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. BioRxiv. 2020.
  8. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720. PubMed:
  9. Chen N, Zhou M, Dong X, Qu J, Gong F, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395: 507–513. PubMed:
  10. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: Management and challenges. Lancet Gastroenterol Hepatol. 2020; 5: 428-430. PubMed:
  11. Zhang B, Zhou X, Qiu Y, Feng F, Feng J, et al. Clinical characteristics of 82 death cases with COVID-19. MedRxiv. 2020.
  12. Huang Y, Zhou H, Yang R, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv; 2020.
  13. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, et al. Characteristics of Liver Tests in COVID-19 Patients. J Hepatol. 2020.
  14. Fan Z, Chen L, Li J, Tian C, Zhang Y, et al. Clinical features of COVID-19 related liver damage. MedRxiv. 2020.
  15. Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, et al. Kupffer Cell-Dependent Hepatitis Occurs during Influenza Infection Am J Pathol. 2006; 168: 1169-1178. PubMed:
  16. Yao XH, Li TY, He ZC, Ping YF, Liu HW, et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020; 49: 411-417. PubMed:
  17. Xu Z, Shi L, Wang Y, Zhang J, Huang L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8: 420–422. PubMed:
  18. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40: 998-1004. PubMed:
  19. Boettler T, Newsome PN , Mondelli MU. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020; 2: 100113. PubMed:
  20. American Society of Transplantation. 2019-nCoV (Coronavirus): FAQs for organ donation and transplantation. 2020.
  21. Ji D, Qin E, Xu J, Zhang D, Cheng G, et al. Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis. J Hepatology. 2020; 73: 451-453. PubMed:
  22. Zhu L, Xu X, Ma K, Yang J, Guan H, et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020; 20: 1859-1863. PubMed:
  23. Schütte A, Ciesek S, Wedemeyer H, Lange CM. Influenza virus infection as precipitating event of acute-on-chronic liver failure. J Hepatol 2019; 70: 797-799. PubMed:
  24. Singh S, Khan A Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study. Gastroenterology. 2020; 159: 768-771.e3. PubMed:
  25. American Society of Transplantation. 2019-nCoV (Coronavirus): FAQs for organ donation and transplantation. 2020.
  26. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020; 323: 1488-1494.     PubMed:
  27. COVID-19 Drug interactions. 2020.
  28. Rich NE, John BV, Parikh ND, Rowe I, Mehta N, et al. Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis. Hepatology. 2020. PubMed:
  29. Angelico R, Trapani S, Manzia TM, Lombardini L, Tisone G, et al. The COVID-19 outbreak in Italy: initial implications for organ transplantation programs. Am J Transplant. 2020; 20: 1780-1784. PubMed: